Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

Here is why Pfizer can't seem to get off the mat and whether it's worth buying the dip on today. I won't rehash Pfizer's pandemic journey too much. The company developed and sold a vaccine (Comirnaty) ...

Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 clinical study of the innovative MesoC2 drug at the ASCO Annual Meeting, and ...

Provident Financial Services shows strong loan growth potential, stable margins, and a 5.8% yield despite market headwinds.

Roche's Itovebi combo gains EMA panel endorsement for advanced breast cancer with PIK3CA mutation. Read more here.

Nvidia is slated to report fiscal first-quarter results after the market closes Wednesday, with Wall Street expecting another ...

Tvardi Therapeutics Inc. stock grades by Barron's. View TVRD fundamental and sentiment analysis powered by MarketGrader.